Caplin Point (India) Today
| CAPLIPOINT | 1,977 12.80 0.65% |
Performance1 of 100
| Odds Of DistressLess than 1
|
Caplin Point is selling at 1976.55 as of the 25th of November 2024; that is 0.65 percent increase since the beginning of the trading day. The stock's open price was 1963.75. Caplin Point has a very small chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Caplin Point Laboratories are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of June 2023 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Caplin Point is entity of India. It is traded as Stock on NSE exchange. The company has 76.01 M outstanding shares. More on Caplin Point Laboratories
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Caplin Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Caplin Point's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Caplin Point or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Health Care (View all Sectors) | ||||
Caplin Point's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Caplin Point's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsCaplin Point can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Caplin Point's financial leverage. It provides some insight into what part of Caplin Point's total assets is financed by creditors.
| |||||
Caplin Point Laboratories (CAPLIPOINT) is traded on National Stock Exchange of India in India and employs 3,406 people. Caplin Point is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 149.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Caplin Point's market, we take the total number of its shares issued and multiply it by Caplin Point's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Caplin Point Laboratories operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 76.01 M outstanding shares.
Caplin Point Laboratories has accumulated about 4.93 B in cash with 3.18 B of positive cash flow from operations.
Check Caplin Point Probability Of Bankruptcy
Ownership AllocationCaplin Point holds a total of 76.01 Million outstanding shares. Caplin Point Laboratories shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.58 percent of Caplin Point Laboratories outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Caplin Ownership Details
Caplin Point Laboratories Risk Profiles
Although Caplin Point's alpha and beta are two of the key measurements used to evaluate Caplin Point's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.21 | |||
| Semi Deviation | 2.23 | |||
| Standard Deviation | 2.96 | |||
| Variance | 8.77 |
Caplin Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Caplin Point without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Caplin Point Corporate Management
Elected by the shareholders, the Caplin Point's board of directors comprises two types of representatives: Caplin Point inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Caplin. The board's role is to monitor Caplin Point's management team and ensure that shareholders' interests are well served. Caplin Point's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Caplin Point's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Natarajan | Head Injectibles | Profile | |
| Partheeban Siddarth | Chief Officer | Profile | |
| Ashok Partheeban | Head Business | Profile | |
| Muralidharan | Chief Officer | Profile | |
| Venkatram | Company Counsel | Profile | |
| Thiagaraja Manikandan | Chief Officer | Profile |
Other Information on Investing in Caplin Stock
Caplin Point financial ratios help investors to determine whether Caplin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Caplin with respect to the benefits of owning Caplin Point security.